This podcast, part 3 of a 3-part series on thyroid eye disease (TED), examines the multidisciplinary management of TED, with a focus on teprotumumab-associated adverse effects. Through expert discussions and case-based examples, listeners will learn best practices for managing hyperglycemia, hearing changes, and other potential complications. The podcast also outlines the essential role of primary eye care professionals in comanaging TED, from early recognition to educating patients and coordinating care with specialists. Listeners will be equipped to apply collaborative strategies to optimize outcomes for patients with TED.
- Provider:MedEdicus, LLC
- Activity Link: https://courses.mededicus.com/content/thyroid-eye-disease-conversations-comprehensive-comanagement-%E2%80%93-monitoring-cecme-podcast#group-tabs-node-course-default1
- Start Date: 2025-01-15 06:00:00
- End Date: 2025-01-15 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
- Commercial Support: Source: Amgen, Inc. - Amount: 52217.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence
- Provider Ship: Directly Provided
- Registration: Limited
Subscribe
Login
0 Comments
Oldest